Wikidata

(Q60499053)

English

Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report

No description defined

In more languages

Statements

title
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report (English)
0 references
author name string
J Johansson
series ordinal
1
0 references
A G Olsson
series ordinal
2
0 references
L Bergstrand
series ordinal
3
0 references
L S Elinder
series ordinal
4
0 references
S Nilsson
series ordinal
5
0 references
U Erikson
series ordinal
6
0 references
J Mölgaard
series ordinal
7
0 references
I Holme
series ordinal
8
0 references
G Walldius
series ordinal
9
0 references
publication date
August 1995
0 references
volume
15
0 references
issue
8
0 references
page(s)
1049-56
0 references

Identifiers

PubMed ID
7627695
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q60499053&oldid=1831250545"